Douglas G. Cole Insider Trading $EDIT Editas Medicine, Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Douglas G. Cole.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Douglas G. Cole. Douglas G. Cole is Director in AVEO PHARMACEUTICALS INC ($AVEO) and Director in AGIOS PHARMACEUTICALS INC ($AGIO) and Director in Quanterix Corp ($QTRX) and Director in Editas Medicine, Inc. ($EDIT) and Director in Denali Therapeutics Inc. ($DNLI) and Director in Sana Biotechnology, Inc. ($SANA).

Douglas G. Cole in Editas Medicine, Inc.

Trading Symbol: EDIT
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Douglas G. Cole: Director
Holdings: 3,171 shares
Current Value: $58,854
Latest Transaction: Aug 21 2017
$EDIT Market Capitalization: $636.78M
$EDIT Previous Close: $18.56

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Douglas G. Cole in Editas Medicine, Inc.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, AGIO, AVEO, DNLI, EDIT, QTRX, SANA

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Aug 21 2017EDITEditas Medicine, I ...Cole Douglas G.DirectorBuyJ0.001,68603,1711.5 K to 3.2 K (+113.54 %)
Jun 19 2017EDITEditas Medicine, I ...Cole Douglas G.DirectorOption ExerciseA15.6311,538180,33911,538
Aug 15 2016EDITEditas Medicine, I ...Cole Douglas G.DirectorBuyJ0.001,48501,4850 to 1.5 K

Page:   1